Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Not all exons are protein coding: Addressing a common misconception

Aspden JL. et al, (2023), Cell Genomics, 3, 100296 - 100296

2022 Curt Stern Award introduction: Heidi Rehm

Whiffin N., (2023), The American Journal of Human Genetics, 110, 409 - 409

Variant Location Is a Novel Risk Factor for Individuals With Arrhythmogenic Cardiomyopathy Due to a Desmoplakin (DSP) Truncating Variant.

Hoorntje ET. et al, (2022), Circulation. Genomic and precision medicine

Recommendations for clinical interpretation of variants found in non-coding regions of the genome.

Ellingford JM. et al, (2022), Genome medicine, 14

Genetic constraint at single amino acid resolution improves missense variant prioritisation and gene discovery

Zhang X. et al, (2022)

MRSD: A quantitative approach for assessing suitability of RNA-seq in the investigation of mis-splicing in Mendelian disease

Rowlands CF. et al, (2022), The American Journal of Human Genetics

Author Correction: Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals

Whiffin N. et al, (2021), Nature Communications, 12

Non-coding region variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms.

Wright CF. et al, (2021), American journal of human genetics

MRSD: a novel quantitative approach for assessing suitability of RNA-seq in the clinical investigation of mis-splicing in Mendelian disease

Rowlands CF. et al, (2021)

Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect.

Tadros R. et al, (2021), Nature genetics

Author Correction: The effect of LRRK2 loss-of-function variants in humans

Whiffin N. et al, (2021), Nature Medicine

Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals

Whiffin N. et al, (2020), Nature Communications, 11

Non-coding variants upstream of MEF2C cause severe developmental disorder through three distinct loss-of-function mechanisms

Wright C. et al, (2020)

Annotating high-impact 5’untranslated region variants with the UTRannotator

Zhang X. et al, (2020)

The effect of LRRK2 loss-of-function variants in humans

Whiffin N. et al, (2020), Nature Medicine, 26, 869 - 877

Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions

Zhang X. et al, (2020)

The Egyptian Collaborative Cardiac Genomics (ECCO-GEN) Project: defining a healthy volunteer cohort.

Aguib Y. et al, (2020), NPJ genomic medicine, 5

Human loss-of-function variants suggest that partial LRRK2 inhibition is a safe therapeutic strategy for Parkinson’s disease

Whiffin N. et al, (2019)

Characterising the loss-of-function impact of 5’ untranslated region variants in whole genome sequence data from 15,708 individuals

Whiffin N. et al, (2019)

Evaluating potential drug targets through human loss-of-function genetic variation

Minikel EV. et al, (2019)

Load More

Include forthcoming?